Therapeutic Vaccine Combination May Help Patients with Myelodysplastic Syndrome

Leggi l'articolo originale


A new study demonstrates that it is possible to vaccinate patients with MDS against a decitabine-induced antigen and that the level of induced expression is sufficient to trigger cytotoxicity in patient-derived vaccine induced T-cells.

Lascia un commento